All In Biotech

Drug Trial Radar · NCT04393038

ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19

A Phase 2/3, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and the Safety of ABX464 in Treating Inflammation and Preventing COVID-19 Associated Acute Respiratory Failure in Patients Aged ≥ 65 and Patients Aged ≥18 With at Least One Additional Risk Factor Who Are Infected With SARS-CoV-2.

Last checked: Nov 19, 2026Latest source record: Nov 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 509 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

509

Actual

Start

Jul 1, 2020

Primary completion

Mar 5, 2021

Study completion Apr 16, 2021

Sponsor

Lead sponsor
Abivax S.A.Industry
Sponsor type
Industry
First posted
May 19, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase 2/3, randomized, double blind, placebo-controlled study to evaluate the efficacy and the safety of ABX464 in treating inflammation and preventing acute respiratory failure in patients aged ≥65 and patients aged ≥18 with at least one additional risk factor who are infected with SARS-CoV-2 (the MiR-AGE study).

Conditions

  • COVID-19

Interventions

  • ABX464Drug

    ABX464 50mg QD for 28 days + Standard of Care

  • PlaceboDrug

    Placebo 50mg QD for 28 days + Standard of Care

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Responders: i.e. Rate of Patients Who do Not Require Use of High-flow Oxygen Invasive or Non-invasive Mechanical Ventilation (IMV and NIV, Respectively) Within 28 Days and Who Are Alive at the End of the 28 Days Period.Time frame: 28 days

Locations

30 sites in 8 countries. Site status is shown where the registry gives one.

  • Centre hospitalier Saint Pierre

    Brussels, Belgium

  • Hôpital Erasme

    Brussels, Belgium

  • UZ Gent

    Ghent, Belgium

  • Instituto Nacional de Infectologia Evandro Chagas - FIOCRUZ Rio de Janeiro

    Rio de Janeiro, Brazil

  • Conjunto Hospitalar do Mandaqui

    São Paulo, Brazil

  • Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado - Instituto de Pesquisa Clínica Carlos Borborema

    Manaus, Amazonas, Brazil

  • Centro Oncológico de Roraima - CECOR - NAP

    Boa Vista, Roraima, Brazil

  • Hospital das Clinicas da FMUSP

    São Paulo, São Paulo, Brazil

  • Hôpital Nord

    Amiens, France

  • Centre Hospitalier Départemental de Vendée

    La Roche-sur-Yon, France

  • Centre Hospitalier Universitaire de Nice

    Nice, France

  • Hôpital Saint-Antoine

    Paris, France

  • Asklepios Klinik St. Georg

    Hamburg, Germany

  • Asklepios Klinik Altona

    Hamburg, Germany

  • Universitätsmedizin Mannheim Ruprecht-Karls-Universität Heid

    Mannheim, Baden-Wurttemberg, Germany

  • Universitätsklinikum Bonn

    Bonn, North Rhine-Westphalia, Germany

  • Ospedale A. Manzonidi Lecco - ASST Lecco

    Lecco, Italy

  • Ospedale Niguarda

    Milan, Italy

  • Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico - Infectious Diseases

    Milan, Lombardy, Italy

  • Ospedale San Paolo

    Milan, Lombardy, Italy

  • Ospedale Luigi Sacco, AO-PU

    Milan, Lombardy, Italy

  • Ospedale di Vittorio Veneto - Medecina generale

    Vittorio Veneto, Treviso, Italy

  • Centro de Prevención y Rehabilitación de Enfermedades Pulmon

    Nuevo León, Mexico

  • Consultorio médico

    Mérida, Yucatán, Mexico

  • H.G.U. Alicante

    Alicante, Spain

  • Hospital del Mar

    Barcelona, Spain

  • Hospital de La Princesa

    Madrid, Spain

  • Hospital Universitario Infanta Leonor

    Madrid, Spain

  • Hospital Universitari Germans Trias i Pujol

    Badalona, Barcelona, Spain

  • Royal Free Hospital

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.